Risk Factor Treatment in Veteran Women at Risk for Cardiovascular Disease

Risk Factor Treatment in Veteran Women at Risk for Cardiovascular Disease
复制标题

DOI:
10.1016/j.jss.2008.07.014
复制
发表时间:
2009-12-01
影响因子:
2.2
通讯作者:
Bush, Ruth L.
Bush, Ruth L.
中科院分区:
医学3区
文献类型:
--
作者:
Canter, Debra L.;Atkins, Marvin D.;Bush, Ruth L.

文献摘要

被引文献

相似文献

目标。心血管疾病(CVD)是女性死亡的主要原因。积极管理动脉粥样硬化的危险因素可以预防或延缓心血管疾病的发生。治疗可改变的危险因素为减轻女性心血管疾病负担和降低未来不良事件发生率提供了重要机会。这项研究的目的是评估目前对被发现为心血管疾病中或高风险女性的动脉粥样硬化危险因素的治疗,并检查被发现为心血管疾病中风险或高风险女性的心血管知识和意识水平。在一项横断面研究中,我们筛查了40至85岁的女性退伍军人周围血管疾病(PVD)及其相关动脉粥样硬化危险因素的患病率,并进行了一项调查,以评估参与者对心血管疾病、危险因素和后果的知识和认识。对病历、药房数据和临床医生接触记录进行审查,以获得关于心血管疾病危险因素、合并症和相应治疗的书面证据。在162名女性的总队列中,108名(66.7%)被归类为心血管疾病风险增加,这是基于修改的Framingham心血管风险评分,该评分考虑了颈动脉内中膜厚度(CIMT)和踝臂指数(CIMT;1.0 mm)或踝臂指数
Objectives. Cardiovascular disease (CVD) is the leading cause of death in women. Aggressive management of atherosclerotic risk factors can prevent or delay the onset of CVD. Treatment of modifiable risk factors provides an important opportunity to reduce the burden of CVD in women and decrease future adverse event rates. The aims of this study were to assess current treatment of atherosclerotic risk factors in women found to be at moderate or high-risk for CVD and to examine levels of CVD knowledge and awareness among women found to be at moderate or high-risk for CVDMethods. In a cross-sectional study, we screened ambulatory female veterans aged 40 to 85 y for the prevalence of peripheral vascular disease (PVD) and associated atherosclerotic risk factors, and administered a survey to assess the participants' knowledge and awareness of CVD, risk factors, and consequences. Medical records, pharmacy data, and clinician encounter notes were reviewed for documented evidence of CVD risk factors, comorbidities, and corresponding treatment. From a total cohort of 162 women, 108 (66.7%) were categorized as having an increased risk of cardiovascular disease based on a modification of the Framingham cardiovascular risk score, which took into account the presence of carotid intimal-medial thickness (cIMT) > 1.0 mm or ankle-brachial index